Market Overview:
The global organoid kit market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for organoid kits for research and drug development purposes. In addition, rising investments in stem cell research are also propelling the growth of this market. The global organoid kit market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into colon organoid kit, cerebral organoid kit, intestinal organoid kit, and others. The colon Organoids Kit segment is expected to account for a major share of the global Organoids Kit Market due to its growing applications in drug discovery and regenerative medicine.
Product Definition:
The Organoid Kit is a set of tools used to form three-dimensional organ-like structures from stem cells. These organoids can be used for research or drug testing purposes.
Colon Organoid Kit:
Colon organoid kit is used for the cultivation of human intestinal organoids. It's usage facilitates in understanding the molecular mechanisms occurring in diseases and disorders such as inflammatory bowel disease, Crohn's disease, colorectal cancer, and other gastrointestinal (GI) related disorders.
The global colonorganoid kit market is expected to witness lucrative growth over the forecast period owing to increasing research activities conducted by various academic institutes.
Cerebral Organoid Kit:
Cerebral organoid kit is a set of culture medium and growth factors for brain-like structures. It helps in the generation of cerebral organoids that can be used for basic as well as applied research on neurological disorders such as Parkinson's disease, Alzheimer’s disease, Epilepsy and Schizophrenia. Cerebral Organoid Kit (COK) has been developed by researchers at the University of Wisconsin-Madison in collaboration with scientists from Gladstone Institutes.
Application Insights:
The hospital application segment dominated the global organoid kit market in 2017. This can be attributed to growing awareness about stem cell therapies and increasing incidences of chronic diseases, such as diabetes and cancer. According to a study published by NCBI in 2018, it is estimated that around 60-80% of patients suffering from type 2 diabetes will not respond to a single drug therapy but could benefit from regenerative medicine using induced pluripotent stem cells (iPSCs). Thus, growing adoption of these products for clinical trials would provide an impetus to growth.
Clinical trial accounted for the second largest share owing to its ability to directly treat human disease conditions without the need for animal testing or human trials. For instance, according with U.
Regional Analysis:
North America dominated the global organoid kit market in 2017. This can be attributed to the presence of a well-developed healthcare infrastructure, high adoption rate of advanced technologies, and increasing demand for personalized medicine in this region. Moreover, government funding for research activities that include development of organoid kits is also driving the regional market growth.
Asia Pacific is expected to grow at an exponential rate during the forecast period owing to rising number clinical trials being undertaken in this region coupled with growing medical tourism industry supported by low cost treatment options offered by various countries such as Japan and China.
Growth Factors:
- Increasing demand for regenerative medicine and stem cell therapy
- Rising prevalence of chronic diseases such as cancer, diabetes, and heart diseases
- Growing number of organ donors and transplant surgeries
- Technological advancements in organoid kit manufacturing process
- Rising awareness about the benefits of organoid kits
Scope Of The Report
Report Attributes
Report Details
Report Title
Organoid Kit Market Research Report
By Type
Colon Organoid Kit, Cerebral Organoid Kit, Intestinal Organoid Kit, Others
By Application
Hospital, Clinic, Research Center
By Companies
GE, Thermo Fisher Scientific, Merck, Cell Biolabs, Bio-Rad Laboratories, Promega, STEMCELL Technologies, BD, Fibrocell Science
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Organoid Kit Market Report Segments:
The global Organoid Kit market is segmented on the basis of:
Types
Colon Organoid Kit, Cerebral Organoid Kit, Intestinal Organoid Kit, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Research Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE
- Thermo Fisher Scientific
- Merck
- Cell Biolabs
- Bio-Rad Laboratories
- Promega
- STEMCELL Technologies
- BD
- Fibrocell Science
Highlights of The Organoid Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Colon Organoid Kit
- Cerebral Organoid Kit
- Intestinal Organoid Kit
- Others
- By Application:
- Hospital
- Clinic
- Research Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Organoid Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Organoid Kit is a 3D printing kit that allows users to create miniature versions of organs and tissues in the lab. The kit includes a printer, materials, and instructions.
Some of the major companies in the organoid kit market are GE, Thermo Fisher Scientific, Merck, Cell Biolabs, Bio-Rad Laboratories, Promega, STEMCELL Technologies, BD, Fibrocell Science.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Organoid Kit Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Organoid Kit Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Organoid Kit Market - Supply Chain
4.5. Global Organoid Kit Market Forecast
4.5.1. Organoid Kit Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Organoid Kit Market Size (000 Units) and Y-o-Y Growth
4.5.3. Organoid Kit Market Absolute $ Opportunity
5. Global Organoid Kit Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Organoid Kit Market Size and Volume Forecast by Type
5.3.1. Colon Organoid Kit
5.3.2. Cerebral Organoid Kit
5.3.3. Intestinal Organoid Kit
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Organoid Kit Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Organoid Kit Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Research Center
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Organoid Kit Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Organoid Kit Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Organoid Kit Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Organoid Kit Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Organoid Kit Demand Share Forecast, 2019-2026
9. North America Organoid Kit Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Organoid Kit Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Organoid Kit Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Research Center
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Organoid Kit Market Size and Volume Forecast by Type
9.7.1. Colon Organoid Kit
9.7.2. Cerebral Organoid Kit
9.7.3. Intestinal Organoid Kit
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Organoid Kit Demand Share Forecast, 2019-2026
10. Latin America Organoid Kit Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Organoid Kit Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Organoid Kit Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Research Center
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Organoid Kit Market Size and Volume Forecast by Type
10.7.1. Colon Organoid Kit
10.7.2. Cerebral Organoid Kit
10.7.3. Intestinal Organoid Kit
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Organoid Kit Demand Share Forecast, 2019-2026
11. Europe Organoid Kit Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Organoid Kit Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Organoid Kit Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Research Center
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Organoid Kit Market Size and Volume Forecast by Type
11.7.1. Colon Organoid Kit
11.7.2. Cerebral Organoid Kit
11.7.3. Intestinal Organoid Kit
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Organoid Kit Demand Share, 2019-2026
12. Asia Pacific Organoid Kit Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Organoid Kit Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Organoid Kit Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Research Center
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Organoid Kit Market Size and Volume Forecast by Type
12.7.1. Colon Organoid Kit
12.7.2. Cerebral Organoid Kit
12.7.3. Intestinal Organoid Kit
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Organoid Kit Demand Share, 2019-2026
13. Middle East & Africa Organoid Kit Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Organoid Kit Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Organoid Kit Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Research Center
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Organoid Kit Market Size and Volume Forecast by Type
13.7.1. Colon Organoid Kit
13.7.2. Cerebral Organoid Kit
13.7.3. Intestinal Organoid Kit
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Organoid Kit Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Organoid Kit Market: Market Share Analysis
14.2. Organoid Kit Distributors and Customers
14.3. Organoid Kit Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GE
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cell Biolabs
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bio-Rad Laboratories
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Promega
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. STEMCELL Technologies
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BD
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Fibrocell Science
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook